Loading provider…
Loading provider…
Radiation Oncology Physician in Maywood, IL
NPI: 1679550545Primary Practice Location
Loyola University Medical Center
2160 S 1st Ave, IL
HQ Phone
Get MD Edward's Phone Numberphone_androidMobile
Get MD Edward's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
Authors: Kathy Albain, Vikram Prabhu, Ignacio Jusue Torres
Journal: World Neurosurg
Publication Date: 2021-07-10
Multiple Primary Merkel Cell Carcinomas Presenting as Pruritic, Painful Lower Leg Tumors.
Authors: Anthony Peterson, Kelli Hutchens, Laura Blumenthal
Journal: Case Rep Dermatol
Publication Date: 2015-10-29
Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy.
Authors: Vikram Prabhu, Anand Germanwala, Scott Silva, Adam Gliniewicz
Publication Date: 2018-04-19
Lead Sponsor: Canadian Cancer Trials Group
Collaborators: NRG Oncology, Alliance for Clinical Trials in Oncology
Intervention / Treatment: PROCEDURE: Stereotactic Radiosurgery (SRS), DRUG: Memantine, RADIATION: Hippocampal-avoidant (HA-WBRT) Radiotherapy
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Laboratory Biomarker Analysis, PROCEDURE: Biospecimen Collection, OTHER: Clinical Observation, OTHER: Quality-of-Life Assessment, RADIATION: Intensity-Modulated Radiation Therapy, RADIATION: Proton Beam Radiation Therapy
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI), Canadian Cancer Trials Group, European Organisation for Research and Treatment Center (EORTC)
Intervention / Treatment: RADIATION: radiotherapy, DRUG: vincristine, DRUG: CCNU, DRUG: concomitant temozolomide (TMZ), DRUG: procarbazine, DRUG: adjuvant temozolomide (TMZ)